Susan E. Barrowcliffe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Susan E. Barrowcliffe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Susan E. Barrowcliffe. Susan E. Barrowcliffe is General Manager, Europe in Aimmune Therapeutics, Inc. ($AIMT).
Latest Insider Trading Transactions of Susan E. Barrowcliffe
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 40,000 | 120,880 | 53,400 | |
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 30.04 | 40,000 | 1,201,600 | 9,375 | 49.4 K to 9.4 K (-81.01 %) |
Nov 21 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 40,000 | 120,880 | 49,375 | 9.4 K to 49.4 K (+426.67 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Grant | A | 0.00 | 9,375 | 0 | 9,375 | 0 to 9.4 K |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 75,000 | 226,650 | 93,400 | |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.75 | 600 | 22,652 | 0 | 600 to 0 (-100.00 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,400 | 905,716 | 600 | 25 K to 600 (-97.60 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.86 | 300 | 11,359 | 25,000 | 25.3 K to 25 K (-1.19 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.13 | 24,700 | 917,022 | 25,300 | 50 K to 25.3 K (-49.40 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.78 | 599 | 22,629 | 50,000 | 50.6 K to 50 K (-1.18 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 37.12 | 24,401 | 905,811 | 50,599 | 75 K to 50.6 K (-32.53 %) |
Jan 04 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 75,000 | 226,650 | 75,000 | 0 to 75 K |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 20,000 | 60,440 | 168,400 | |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 25.00 | 20,000 | 500,000 | 0 | 20 K to 0 (-100.00 %) |
Sep 27 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 20,000 | 60,440 | 20,000 | 0 to 20 K |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,167 | 45,835 | 188,400 | |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 3,223 | 9,740 | 203,567 | |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 15,167 | 333,709 | 0 | 15.2 K to 0 (-100.00 %) |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,167 | 45,835 | 15,167 | 0 to 15.2 K |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 3,223 | 70,906 | 0 | 3.2 K to 0 (-100.00 %) |
Sep 07 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 3,223 | 9,740 | 3,223 | 0 to 3.2 K |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 500 | 1,511 | 206,790 | |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 500 | 11,000 | 0 | 500 to 0 (-100.00 %) |
Jul 31 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 500 | 1,511 | 500 | 0 to 500 |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 4,650 | 14,052 | 207,290 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 500 | 1,511 | 211,940 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 960 | 2,901 | 212,440 | |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 4,650 | 102,300 | 0 | 4.7 K to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 4,650 | 14,052 | 4,650 | 0 to 4.7 K |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 500 | 11,000 | 0 | 500 to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 500 | 1,511 | 500 | 0 to 500 |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 22.00 | 960 | 21,120 | 0 | 960 to 0 (-100.00 %) |
Jul 25 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 960 | 2,901 | 960 | 0 to 960 |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,000 | 45,330 | 213,400 | |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 20.26 | 15,000 | 303,911 | 0 | 15 K to 0 (-100.00 %) |
Jul 06 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,000 | 45,330 | 15,000 | 0 to 15 K |
Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 20,000 | 60,440 | 228,400 | |
Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 25.00 | 20,000 | 500,000 | 0 | 20 K to 0 (-100.00 %) |
Nov 15 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 20,000 | 60,440 | 20,000 | 0 to 20 K |
Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | M | 3.02 | 15,000 | 45,330 | 248,400 | |
Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Sell | S | 20.00 | 15,000 | 300,000 | 0 | 15 K to 0 (-100.00 %) |
Nov 10 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Buy | M | 3.02 | 15,000 | 45,330 | 15,000 | 0 to 15 K |
Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 16.93 | 80,000 | 1,354,400 | 80,000 |
Page: 1